Elongated supramolecular assemblies in drug delivery (Q34626072)

3 August 2017

1 reference

title

Elongated supramolecular assemblies in drug delivery (English)

1 reference

3 August 2017

1 reference

Leila Zarif

1

1 reference

PubMed ID

11992674

3 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Journal of Controlled Release

3 August 2017

1 reference

3 August 2017

81

1 reference

3 August 2017

1-2

1 reference

3 August 2017

7-23

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

3 August 2017

1 reference

7 January 2021

Biodegradable poly (lactic acid) microspheres for drug delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Polyacrylamide-chitosan hydrogels: in vitro biocompatibility and sustained antibiotic release studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

PCL-b-PEO micelles as a delivery vehicle for FK506: assessment of a functional recovery of crushed peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Polymeric contrast agents for medical imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Polymer-coated long-circulating microparticulate pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Lipid tubules: a paradigm for molecularly engineered structures

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Structure of lipid tubules formed from a polymerizable lecithin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Theory of chiral lipid tubules

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Diacetylenic lipid tubules: experimental evidence for a chiral molecular architecture

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Formation of high-axial-ratio-microstructures from natural and synthetic sphingolipids

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Bilayer nanotubes and helical ribbons formed by hydrated galactosylceramides: acyl chain and headgroup effects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Formation of high axial ratio microstructures from peptides modified with glutamic acid dialkyl amides.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Self-assembly comes together

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Probing the structure of diacetylenic phospholipid tubules with fluorescent lipophiles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Controlled release from cylindrical microstructures

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Insertion of bacteriorhodopsin into polymerized diacetylenic phosphatidylcholine bilayers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Zero-order interfacial enzymatic degradation of phospholipid tubules

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Ca2+-induced fusion of phospholipid vesicles monitored by mixing of aqueous contents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Incorporation of macromolecules within large unilamellar vesicles (LUV)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Targeting immune response induction with cochleate and liposome-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Encapsulation of bilayer vesicles by self-assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Amphotericin B nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Treatment of murine candidosis and cryptococcosis with a unilamellar liposomal amphotericin B formulation (AmBisome)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Lipid formulations of amphotericin B: clinical efficacy and toxicities

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Effects of phosphatidylserine in age-associated memory impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Effects of phosphatidylserine therapy in geriatric patients with depressive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Effective treatment of acute and chronic murine tuberculosis with liposome-encapsulated clofazimine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Comparative internalization and recycling of different amphotericin B formulations by a macrophage-like cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Molecular mechanisms of erythrophagocytosis. Characterization of the senescent erythrocytes that are phagocytized by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Unusual lipid structures selectively reduce the toxicity of amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

The interaction of liposomal amphotericin B and serum lipoproteins within the biological milieu

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Amphotericin B lipid complex therapy of experimental fungal infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Lipid formulations of amphotericin B: recent progress and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Renal effects of amphotericin B lipid complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Amphotericin B lipid complex (ABLC)-associated hypertension: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Amphotericin B lipid complex in pediatric patients with invasive fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

Comparative Safety, Tolerance, and Pharmacokinetics of Amphotericin B Lipid Complex and Amphotericin B Desoxycholate in Healthy Male Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900010-X

7 January 2021

10.1016/S0168-3659(02)00010-X

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11992674